No Data
BLCO Bausch + Lomb Corp.
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Bausch + Lomb Corp. Company
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Revenue Breakdown
News
Bausch + Lomb Introduces New Hypoallergenic Eye Care Range Lumify
Bausch + Lomb (BLCO) said Tuesday it has introduced a new range of hypoallergenic specialty eye care products in the US, known as Lumify Eye Illuminations. The product line includes a micellar cleansi
Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS in the United States
Bausch Health Stock Rebounds From Tuesday Sell-off, Helped by Jefferies Upgrade
Comments
ColumnsUS Top Rating Updates on 9/12: ADBE, OXY, RBLX, UNP and More
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
ColumnsUS Top Rating Updates on 9/9: MMM, REGN, ENPH, PSNY and More
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
MettOP : Took half off at 1R